What is it and why is it prescribed?
Xarelto® (rivaroxaban) is one of the newest blood thinners on the market and was approved in 2011. It is manufactured by Bayer and marketed in the U.S. by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals. It is widely prescribed to prevent blood clots in patients with atrial fibrillation, deep vein thrombosis, pulmonary embolism, stroke, and those who have recently undergone a knee or hip replacement surgery.
Xarelto® is often marketed as an alternative to Coumadin (Warfarin), an older treatment that requires patients to undergo frequent tests and adhere to a strict diet. Patients and doctors are drawn to Xarelto® because it is a more convenient treatment option, not requiring routine blood work.
According to the Wall Street Journal, “Xarelto® , which is approved for stroke prevention in patients with atrial fibrillation, and treating and preventing deep vein thrombosis and pulmonary embolism, is expected to generate more than $1 billion in sales this year.” Xarelto® is one of Bayer’s top five medicines, reported Reuters.
What are the risks of using Xarelto® ?
The most dangerous side effect for using Xarelto® is uncontrollable internal bleeding bleeding. Xarelto® is more dangerous than traditional blood thinners because no antidote exists to reverse or stop bleeding. In 2014, Boehringer Ingelheim paid $650 million to settle 4,000 Pradaxa Lawsuits. Pradaxa was a similar blood thinner that, like Xarelto® , did not have an antidote to reverse or stop internal bleeding.
Other potential injuries caused through the use of Xarelto® include infection associated with hip or knee replacement surgery; decreased hemoglobin, cerebrovascular accidents (which can lead to a cerebral hemorrhage), hematoma, swelling of the lower limbs, and difficulty breathing. In a study published by the Bone & Joint Journal, patients who were given Rivaroxaban (Xarelto® ) versus another blood thinning medication had a 27% increase in wound oozing after hip or knee arthroplasty.
Last May, the Institute for Safe Medicines Practices, a watchdog group, issued a report noting that blood thinners are a “high risk treatment.” They also reported that as prescriptions of Xarelto® have increased, so have the amount of cases of serious adverse effects on patients. “Anticoagulant drugs are a high-risk treatment and cause bleeding in approximately 15% of patients with atrial fibrillation exposed for a year,” reported The Institute for Safe Medicines Practices.
Why file a lawsuit?
The blood thinner Xarelto® is known to cause uncontrolled bleeding in some patients, and without an antidote to stop the bleeding. It can be fatal. In other cases, it may require hospitalization. Users and family members can seek compensation from the manufacturer of Xarelto® . In most lawsuits filed, former Xarelto® users say they were not fully warned about the medication’s fatal risks or the fact that the drug does not have an antidote like it’s sister drug Coumadin (Warafin). Xarelto® Lawsuits have also filed for financial hardship caused by medical treatment, emotional distress, and the burden of funeral expenses. A Xarelto® lawsuit is the only way to hold Bayer and Janssen pharmaceuticals accountable for releasing this dangerous drug.
Why you need a lawyer
Since June 2015, over 500 Xarelto® lawsuits have been filed against Bayer. The location for the first trial has been set in Lousiana, according to MarketWatch, and could take place as early as August 2016.
In order to receive proper compensation in a Xarelto® lawsuit, you need a skilled group of lawyers to work against such big pharmaceutical companies. We have years of experience working against medical and pharmaceutical companies in order to help our clients get the compensation they deserve. A Xarelto® lawsuit is the best way to be financially and emotionally compensated for damages incurred by using this dangerous drug.